Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?

October 19, 2021 |
‘They rushed the process’: Vaccine maker’s woes hamper global inoculation campaign
Gates Foundation will provide $120 million to ensure generic production of Merck’s Covid-19 pill
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...